BioDlink

Focus: BioDlink is a China-based biotech company specializing in biosimilars, monoclonal antibodies, gene therapy, and vaccines with a focus on infectious diseases and gene therapy. Founded in 2010, the company operates from Jiangsu and maintains an active clinical pipeline.

Infectious Diseases Gene Therapy Vaccines

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About BioDlink

AI assessmentNot Hiring

No open roles listed right now. Follow BioDlink to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

TAB014 Monoclonal Antibody Injection

Neovascular Age-related Macular Degeneration

Phase 3

TAB008

Efficacy

Phase 3

Clinical Trials (1)

Help build intelligence for BioDlink

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Active Phase 3 programs in high-value areas (mAb for ophthalmology, general efficacy programs) signal near-term clinical catalysts
Exposure to fast-growing biotech verticals including gene therapy, vaccines, and biosimilars across infectious disease markets
Founded 2010 with 14+ year operational history suggests organizational stability and established infrastructure

Watch Out For

Zero active job openings and no hiring data provided signal potential organizational contraction or hiring freeze
Minimal public data on financials, funding, employee count, and revenue create visibility risk for career planning
Single clinical trial across entire pipeline (TAB008) and lack of marketed products indicate pre-commercial stage with delayed revenue recognition

Generated by Claude from BioDlink's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

NCT05427305TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer

Phase 3

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Founded: 2010

Portfolio: 1 clinical trial

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo